vedolizumab
takeda
['vedolizumab', 'crohn', 'ibd']
vedolizumab treatment resulted in significantly higher steroid-free clinical and endoscopic remission in patients with early crohn's disease vs late crohn's disease #gitwitter #ibd #uegweek 
The Lancet Gastroenterology & Hepatology publishes high-quality peer-reviewed research and reviews, comment, and news #gastroenterology #hepatology. IF=45.042